Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison
| No. | 83 |
|---|---|
| Citation | Platelets. Apr 15:1-6 (2021) |
| Institute | University of Ottawa Heart Institute, Canada |
| 1st Author | CR Clifford |
| AR | 〇 |
| PL | 〇 |
| HD | |
| Paper types | Basic research |
| Main purpose | Provide a first in vitro comparison of DAPT versus Dual Pathway(DP) approach at clinically proven doses |
| Disease | |
| Antiplatelet drug | aspirin, ticagrelor |
| Anticoagulant drug | rivaroxaban |
| Other drug | |
| Clinical specimens | |
| Animal | |
| Keyword | Direct oral anticoagulants; dual antiplatelet therapy; myocardial infarction; percutaneous coronary intervention; total thrombus analysis system |